Welcome to the summer cinema season, where movie studios vie to capture big bucks using big stars, blockbuster action and preposterous scripts. This season's oeuvre pits Mission: Impossible's Tom Cruise against a fictional biotech company that suspiciously resembles an evil twin to a real company with honest-to-goodness products.

In the Hollywood blockbuster M:I-2, the similarity between the fictional Biocyte Pharmaceuticals (Sydney, Australia) and the real Biota Holdings Ltd. (ASX:BTA; BTAHY, Melbourne, Australia) appears too close to be entirely coincidental. In the movie, Biocyte